Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver.

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	197-201
Number of pages	5
Journal	Cancer Chemotherapy and Pharmacology
Volume	48(3)
Issue number	3
Publication status	Published - 2001

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{7f644aeef57e4e068aca14fc7b00d8c0,

title = "Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver.",

author = "Martin Eatock",

year = "2001",

language = "English",

volume = "48(3)",

pages = "197--201",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "3",

}

TY - JOUR

T1 - Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver.

AU - Eatock, Martin

PY - 2001

Y1 - 2001

UR - https://www.scopus.com/pages/publications/17944369127

M3 - Article

C2 - 11592340

SN - 0344-5704

VL - 48(3)

SP - 197

EP - 201

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 3

ER -